<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38481394</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1179-1594</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Risk management and healthcare policy</Title><ISOAbbreviation>Risk Manag Healthc Policy</ISOAbbreviation></Journal><ArticleTitle>Four Years Since COVID-19 Day Zero: A Time to Evaluate Past and Future Pandemic Control Policies and Practices in Sub-Saharan Africa?</ArticleTitle><Pagination><StartPage>505</StartPage><EndPage>511</EndPage><MedlinePgn>505-511</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/RMHP.S449701</ELocationID><Abstract><AbstractText>Four years after the first case of COVID-19, the world is still determining how best to prevent and control the long-term effects of SARS-CoV-2 infection. Non-pharmaceutical interventions (NPIs) were employed at the start of the pandemic as the only available options, prior to effective vaccines and antiviral agents. The World Health Organization recommended dual vaccination for 70% worldwide as the threshold for a return to "normal" community life. Immunization rates needed to increase in all global regions, irrespective of socioeconomic status, necessitating more equitable access. During the pandemic, wealthier countries hoarded vaccine supplies even when their citizens were immunized. This highlights the already enormous difficulties in healthcare provision faced by low-income sub-Saharan African countries, which remain at risk as industrialized nations have progressed to a post-pandemic era. Thus, in addition to redoubling vaccination efforts public health policymakers should consider ongoing and future use of NPIs. In this narrative account, we advocate that various NPI practices should not be shelved; rather, more research is needed to evaluate their impact in parallel with booster vaccination. This especially applies to so-called "long COVID". Lessons learned from implementing best practices in resource-limited settings should be incorporated into preparedness guidelines for future infectious disease outbreaks.</AbstractText><CopyrightInformation>&#xa9; 2024 Oleribe et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oleribe</LastName><ForeName>Obinna O</ForeName><Initials>OO</Initials><Identifier Source="ORCID">0000-0002-9017-894X</Identifier><AffiliationInfo><Affiliation>Office of the Director-General, Nigerian Institute for Medical Research, Lagos, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Best Health Consult Limited Liability Company, Orange, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor-Robinson</LastName><ForeName>Andrew W</ForeName><Initials>AW</Initials><Identifier Source="ORCID">0000-0001-7342-8348</Identifier><AffiliationInfo><Affiliation>College of Health Sciences, VinUniversity, Hanoi, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nwanyanwu</LastName><ForeName>Okey C</ForeName><Initials>OC</Initials><AffiliationInfo><Affiliation>Fast Forward Africa Limited Liability Company, Austin, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>Marsha Y</ForeName><Initials>MY</Initials><Identifier Source="ORCID">0000-0001-6134-1026</Identifier><AffiliationInfo><Affiliation>Division of Medicine, Royal Free Campus, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor-Robinson</LastName><ForeName>Simon D</ForeName><Initials>SD</Initials><Identifier Source="ORCID">0000-0002-8811-1834</Identifier><AffiliationInfo><Affiliation>Departments of Medicine &amp; Public Health, Busitema University, Mbale, Uganda.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, St Mary's Hospital Campus, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Risk Manag Healthc Policy</MedlineTA><NlmUniqueID>101566264</NlmUniqueID><ISSNLinking>1179-1594</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">health inequality</Keyword><Keyword MajorTopicYN="N">non-pharmaceutical interventions</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword><Keyword MajorTopicYN="N">sub-Saharan Africa</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>14</Day><Hour>3</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38481394</ArticleId><ArticleId IdType="pmc">PMC10933518</ArticleId><ArticleId IdType="doi">10.2147/RMHP.S449701</ArticleId><ArticleId IdType="pii">449701</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Oleribe OO, Osita-Oleribe P, Salako BL, Ishola TA, Fertleman M, Taylor-Robinson SD. COVID-19 experience: taking the right steps at the right time to prevent avoidable morbidity and mortality in Nigeria and other nations of the world. Int J Gen Med. 2020;13:491&#x2013;495. doi:10.2147/ijgm.s261256</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/ijgm.s261256</ArticleId><ArticleId IdType="pmc">PMC7429220</ArticleId><ArticleId IdType="pubmed">32848447</ArticleId></ArticleIdList></Reference><Reference><Citation>Oleribe OO, Oskouipour P, Nwanyanwu O, Taylor-Robinson SD. The COVID-19 era: the view from Nigeria. QJM. 2021;114(1):13&#x2013;15. doi:10.1093/qjmed/hcaa297</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcaa297</ArticleId><ArticleId IdType="pmc">PMC7665780</ArticleId><ArticleId IdType="pubmed">33118021</ArticleId></ArticleIdList></Reference><Reference><Citation>Oleribe O, Ezechi O, Osita-Oleribe P, et al. Public perception of COVID-19 management and response in Nigeria: a cross-sectional survey. BMJ Open. 2020;10(10):e041936. doi:10.1136/bmjopen-2020-041936</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-041936</ArticleId><ArticleId IdType="pmc">PMC7559048</ArticleId><ArticleId IdType="pubmed">33055123</ArticleId></ArticleIdList></Reference><Reference><Citation>Oleribe O, Miller R, Wadzeck M, et al. Klamath tribal response to the pandemic of COVID-19 among Klamath tribal community in Oregon, USA. Glob Adv Health Med. 2021;10:21649561211034470. doi:10.1177/21649561211034470</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21649561211034470</ArticleId><ArticleId IdType="pmc">PMC8287354</ArticleId><ArticleId IdType="pubmed">34350066</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497&#x2013;506. doi:10.1016/s0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlman S. Another decade, another coronavirus. N Engl J Med. 2020;382(8):760&#x2013;762. doi:10.1056/nejme2001126</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejme2001126</ArticleId><ArticleId IdType="pmc">PMC7121143</ArticleId><ArticleId IdType="pubmed">31978944</ArticleId></ArticleIdList></Reference><Reference><Citation>Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281&#x2013;286. doi:10.1007/s12098-020-03263-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12098-020-03263-6</ArticleId><ArticleId IdType="pmc">PMC7090728</ArticleId><ArticleId IdType="pubmed">32166607</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507&#x2013;513. doi:10.1016/s0140-6736(20)30211-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus Pandemic (COVID-19). Our World In Data. Available from: https://ourworldindata.org/coronavirus. Accessed January
31, 2024.</Citation></Reference><Reference><Citation>World Health Organization. Statement on the second meeting of the International Health Regulations(2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV); 2020. Available from: https://www.who.int/news-room/detail/30-01-2020-statement-on-The-second-meeting-of-The-international-health-regulations-(2005)-emergency-committee-regarding-The-outbreak-of-novel-coronavirus-(2019-ncov). Accessed January
31, 2024.</Citation></Reference><Reference><Citation>World Health Organization. WHO Director-General&#x2019;s opening remarks at the media briefing on COVID-19 &#x2013; march 11; 2020. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-The-media-briefing-on-covid-19---11-march-2020. Accessed January
31, 2024.</Citation></Reference><Reference><Citation>World Health Organization. Novel Coronavirus (2019nCoV): strategic Preparedness and Response Plan. Draft as of February 3, 2020.; 2019. Available from: https://www.who.int/docs/default-source/coronaviruse/srp-04022020.pdf. Accessed January
31, 2024.</Citation></Reference><Reference><Citation>Choi AJ, Hean AC, Lee JK, Tran ND, Lin TK, Apollonio DE. A retrospective global assessment of factors associated with COVID-19 policies and health outcomes. Front Public Health. 2022;10:843445. doi:10.3389/fpubh.2022.843445</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.843445</ArticleId><ArticleId IdType="pmc">PMC9125067</ArticleId><ArticleId IdType="pubmed">35615034</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudi SK, Chhabra M, Undela K, et al. Knowledge and beliefs towards universal safety precautions during the coronavirus disease (COVID-19) pandemic among the Indian public: a web-based cross-sectional survey. Drugs Ther Perspect. 2020;36(9):413&#x2013;420. doi:10.1007/s40267-020-00752-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40267-020-00752-8</ArticleId><ArticleId IdType="pmc">PMC7334629</ArticleId><ArticleId IdType="pubmed">32837191</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauci AS, Lane HC, Redfield RR. Covid-19 &#x2014; navigating the uncharted. N Engl J Med. 2020;382(13):1268&#x2013;1269. doi:10.1056/nejme2002387</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejme2002387</ArticleId><ArticleId IdType="pmc">PMC7121221</ArticleId><ArticleId IdType="pubmed">32109011</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Rational use of personal protective equipment (PPE) for coronavirus disease 2019 (COVID-19). Interim Guidance. 2020;19.</Citation></Reference><Reference><Citation>World Health Organization. Rational use of personal protective equipment for COVID-19 and considerations during severe shortages. Interim guidance; 2020. Available from: https://iris.who.int/bitstream/handle/10665/338033/WHO-2019-nCoV-IPC_PPE_use-2020.4-eng.pdf. Accessed January
31, 2024.</Citation></Reference><Reference><Citation>Bavel JJ, Baicker K, Boggio PS, et al. Using social and behavioural science to support COVID-19 pandemic response. Nat Hum Behav. 2020;4(5):460&#x2013;471. doi:10.1038/s41562-020-0884-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41562-020-0884-z</ArticleId><ArticleId IdType="pubmed">32355299</ArticleId></ArticleIdList></Reference><Reference><Citation>Raju E, Ayeb-Karlsson S. COVID-19: how do you self-isolate in a refugee camp?. Int J Public Health. 2020;65(5):515&#x2013;517. doi:10.1007/s00038-020-01381-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00038-020-01381-8</ArticleId><ArticleId IdType="pmc">PMC7206218</ArticleId><ArticleId IdType="pubmed">32385541</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristanto H, Jaya NSP. Hospital criminal liability as a corporation of patient rejection in infected with Covid-19. Leg J Ilm Ilmu Huk. 2020;28(2):146&#x2013;157. doi:10.22219/ljih.v28i2.12168</Citation><ArticleIdList><ArticleId IdType="doi">10.22219/ljih.v28i2.12168</ArticleId></ArticleIdList></Reference><Reference><Citation>Marome W, Shaw R. COVID-19 response in Thailand and its implications on future preparedness. Int J Environ Res Public Health. 2021;18(3):1089. doi:10.3390/ijerph18031089</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18031089</ArticleId><ArticleId IdType="pmc">PMC7908435</ArticleId><ArticleId IdType="pubmed">33530526</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider N, Osman AY, Gadzekpo A, et al. Lockdown measures in response to COVID-19 in nine sub-Saharan African countries. BMJ Glob Health. 2020;5(10):e003319. doi:10.1136/bmjgh-2020-003319</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2020-003319</ArticleId><ArticleId IdType="pmc">PMC7542624</ArticleId><ArticleId IdType="pubmed">33028699</ArticleId></ArticleIdList></Reference><Reference><Citation>Paredes Ruvalcaba N, Kim AW, Ndaba N, et al. Coping mechanisms during the COVID-19 pandemic and lockdown in metropolitan Johannesburg, South Africa: a qualitative study. Am J Hum Biol. 2023;35(12):e23958. doi:10.1002/ajhb.23958</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajhb.23958</ArticleId><ArticleId IdType="pmc">PMC10776812</ArticleId><ArticleId IdType="pubmed">37427489</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendavid E, Oh C, Bhattacharya J, Ioannidis JPA. Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19. Eur J Clin Invest. 2021;51(4):e13484. doi:10.1111/eci.13484</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13484</ArticleId><ArticleId IdType="pmc">PMC7883103</ArticleId><ArticleId IdType="pubmed">33400268</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor S, Landry CA, Rachor GS, Paluszek MM, Asmundson GJG. Fear and avoidance of healthcare workers: an important, under-recognized form of stigmatization during the COVID-19 pandemic. J Anxiety Disord. 2020;75:102289. doi:10.1016/j.janxdis.2020.102289</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.janxdis.2020.102289</ArticleId><ArticleId IdType="pmc">PMC7434636</ArticleId><ArticleId IdType="pubmed">32853884</ArticleId></ArticleIdList></Reference><Reference><Citation>Moroni F, Gramegna M, Ajello S, et al. Collateral damage: medical care avoidance behavior among patients with myocardial infarction during the COVID-19 pandemic. JACC Case Rep. 2020;2(10):1620&#x2013;1624. doi:10.1016/j.jaccas.2020.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2020.04.010</ArticleId><ArticleId IdType="pmc">PMC7252183</ArticleId><ArticleId IdType="pubmed">32835261</ArticleId></ArticleIdList></Reference><Reference><Citation>McDougall RJ, Gillam L, Ko D, Holmes I, Delany C. Balancing health worker well-being and duty to care: an ethical approach to staff safety in COVID-19 and beyond. J Med Ethics. 2021;47(5):318&#x2013;323. doi:10.1136/medethics-2020-106557</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/medethics-2020-106557</ArticleId><ArticleId IdType="pubmed">32978305</ArticleId></ArticleIdList></Reference><Reference><Citation>Routen A, Darko N, Willis A, Miksza J, Khunti K. &#x201c;It&#x2019;s so tough for us now&#x201d; &#x2013; COVID-19 has negatively impacted religious practices relating to death among minority ethnic groups. Public Health. 2021;194:146&#x2013;148. doi:10.1016/j.puhe.2021.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2021.03.007</ArticleId><ArticleId IdType="pubmed">33906088</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Lunz Trujillo K, Green J, et al. Misinformation, trust, and use of ivermectin and hydroxychloroquine for COVID-19. JAMA Health Forum. 2023;4(9):e233257. doi:10.1001/jamahealthforum.2023.3257</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2023.3257</ArticleId><ArticleId IdType="pmc">PMC10542734</ArticleId><ArticleId IdType="pubmed">37773507</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo S, Scuccato R, Fadda A, Cumbi AJ. COVID-19 in Africa: the little we know and the lot we ignore. Epidemiol Prev. 2020;44(5&#x2013;6 Suppl 2):408&#x2013;422. doi:10.19191/ep20.5-6.s2.146</Citation><ArticleIdList><ArticleId IdType="doi">10.19191/ep20.5-6.s2.146</ArticleId><ArticleId IdType="pubmed">33412836</ArticleId></ArticleIdList></Reference><Reference><Citation>Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna vaccines. Eur Rev Med Pharmacol Sci. 2021;25(3):1663&#x2013;1669. doi:10.26355/eurrev_202102_24877</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202102_24877</ArticleId><ArticleId IdType="pubmed">33629336</ArticleId></ArticleIdList></Reference><Reference><Citation>Coustasse A, Kimble C, Maxik K. COVID-19 and vaccine hesitancy: a challenge the United States must overcome. J Ambul Care Manage. 2021;44(1):71&#x2013;75. doi:10.1097/jac.0000000000000360</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/jac.0000000000000360</ArticleId><ArticleId IdType="pubmed">33165121</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridman A, Gershon R, Gneezy A. COVID-19 and vaccine hesitancy: a longitudinal study. PloS One. 2021;16(4):e0250123. doi:10.1371/journal.pone.0250123</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0250123</ArticleId><ArticleId IdType="pmc">PMC8051771</ArticleId><ArticleId IdType="pubmed">33861765</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras S, &#xc1; O-N, Priesemann V. Rethinking COVID-19 vaccine allocation: it is time to care about our neighbours. Lancet Reg Health Eur. 2022;12:100277. doi:10.1016/j.lanepe.2021.100277</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100277</ArticleId><ArticleId IdType="pmc">PMC8633795</ArticleId><ArticleId IdType="pubmed">34870258</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Covid-19: countries dump vaccines as demand slumps and sharing proves difficult. BMJ. 2021;374:n1893. doi:10.1136/bmj.n1893</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1893</ArticleId><ArticleId IdType="pubmed">34315725</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz JR, Robertson J, Hsu J-S, et al. The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region. Vaccine. 2021;39(15):2165&#x2013;2176. doi:10.1016/j.vaccine.2021.02.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.02.037</ArticleId><ArticleId IdType="pmc">PMC7894202</ArticleId><ArticleId IdType="pubmed">33744049</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham SAA, Amoah JO, Agyare DF, et al. Health service factors affecting the COVID-19 vaccination campaign in a Ghanaian metropolis: a qualitative exploratory study. BMJ Open. 2023;13(12):e076184. doi:10.1136/bmjopen-2023-076184</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-076184</ArticleId><ArticleId IdType="pmc">PMC10749017</ArticleId><ArticleId IdType="pubmed">38128932</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogunkola IO, Esu EB, Adebisi YA, Lin X, Li H. Can Africa achieve herd immunity?. Glob Health Res Policy. 2021;6(1):46. doi:10.1186/s41256-021-00231-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41256-021-00231-1</ArticleId><ArticleId IdType="pmc">PMC8636285</ArticleId><ArticleId IdType="pubmed">34852844</ArticleId></ArticleIdList></Reference><Reference><Citation>Mistry P, Barmania F, Mellet J, et al. SARS-CoV-2 variants, vaccines, and host immunity. Front Immunol. 2022;12:809244. doi:10.3389/fimmu.2021.809244</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.809244</ArticleId><ArticleId IdType="pmc">PMC8761766</ArticleId><ArticleId IdType="pubmed">35046961</ArticleId></ArticleIdList></Reference><Reference><Citation>France 24 News Wires. Europe could be headed towards end of pandemic after Omicron, says WHO; 2022. Available from: https://www.france24.com/en/europe/20220123-europe-could-be-headed-towards-end-of-pandemic-after-omicron-says-who. Accessed January
31, 2024.</Citation></Reference><Reference><Citation>World Economic Forum. Does Omicron mean the end for COVID-19? Anthony Fauci and other experts on Radio Davos; 2022. Available from: https://www.weforum.org/agenda/2022/01/omicron-end-of-covid-19-anthony-fauci-radio-davos/. Accessed January
31, 2024.</Citation></Reference><Reference><Citation>World Health Organization Regional Office for Africa. COVID-19 Incident Management Support Team Monthly Bulletin; 2022. Available from: https://www.afro.who.int/sites/default/files/2022-09/IMST-COVID-19202203-eng.pdf%20MARCH.pdf. Accessed January
31, 2024.</Citation></Reference><Reference><Citation>Reuters. COVID-19 TRACKER; 2022. Available from: https://graphics.reuters.com/world-coronavirus-tracker-and-maps/regions/africa/. Accessed January
31, 2024.</Citation></Reference><Reference><Citation>Thenon N, Peyre M, Huc M, Tour&#xe9; A, Roger F, Mangiarotti S. COVID-19 in Africa: underreporting, demographic effect, chaotic dynamics, and mitigation strategy impact. PLoS Negl Trop Dis. 2022;16(9):e0010735. doi:10.1371/journal.pntd.0010735</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0010735</ArticleId><ArticleId IdType="pmc">PMC9518880</ArticleId><ArticleId IdType="pubmed">36112718</ArticleId></ArticleIdList></Reference><Reference><Citation>Renzaho AMN. The need for the right socio-economic and cultural fit in the COVID-19 response in sub-Saharan Africa: examining demographic, economic political, health, and socio-cultural differentials in COVID-19 morbidity and mortality. Int J Environ Res Public Health. 2020;17(10):3445. doi:10.3390/ijerph17103445</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17103445</ArticleId><ArticleId IdType="pmc">PMC7277405</ArticleId><ArticleId IdType="pubmed">32429123</ArticleId></ArticleIdList></Reference><Reference><Citation>United Nations News. WHO chief declares end to COVID-19 as a global health emergency; 2023. Available from: https://news.un.org/en/story/2023/05/1136367. Accessed January
31, 2024.</Citation></Reference><Reference><Citation>Schr&#xf6;der M, Bossert A, Kersting M, et al. COVID-19 in South Africa: outbreak despite interventions. Sci Rep. 2021;11(1):4956. doi:10.1038/s41598-021-84487-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84487-0</ArticleId><ArticleId IdType="pmc">PMC7925578</ArticleId><ArticleId IdType="pubmed">33654164</ArticleId></ArticleIdList></Reference><Reference><Citation>Matovu JK, Mulyowa A, Akorimo R, Kirumira D. Knowledge, risk-perception, and uptake of COVID-19 prevention measures in sub-Saharan Africa: a scoping review. Afr Health Sci. 2022;22(3):542&#x2013;560. doi:10.4314/ahs.v22i3.59</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/ahs.v22i3.59</ArticleId><ArticleId IdType="pmc">PMC9993314</ArticleId><ArticleId IdType="pubmed">36910342</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaechi UA, Sodipo BO, Nnaji CA, et al. Social approaches to COVID-19 pandemic response: effectiveness and practicality in sub-Saharan Africa. Pan Afr Med J. 2020;37(2). doi:10.11604/pamj.supp.2020.37.2.25183</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.supp.2020.37.2.25183</ArticleId><ArticleId IdType="pmc">PMC7704349</ArticleId><ArticleId IdType="pubmed">33294103</ArticleId></ArticleIdList></Reference><Reference><Citation>Proverbio D, Kemp F, Magni S, et al. Dynamical SPQEIR model assesses the effectiveness of non-pharmaceutical interventions against COVID-19 epidemic outbreaks. PLoS One. 2021;16(5):e0252019. doi:10.1371/journal.pone.0252019</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0252019</ArticleId><ArticleId IdType="pmc">PMC8139462</ArticleId><ArticleId IdType="pubmed">34019589</ArticleId></ArticleIdList></Reference><Reference><Citation>Diallo I, Ndejjo R, Leye MMM, et al. Unintended consequences of implementing non-pharmaceutical interventions for the COVID-19 response in Africa: experiences from DRC, Nigeria, Senegal, and Uganda. Global Health. 2023;19(1):36. doi:10.1186/s12992-023-00937-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12992-023-00937-6</ArticleId><ArticleId IdType="pmc">PMC10241604</ArticleId><ArticleId IdType="pubmed">37280682</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawuki J, Chan PS-F, Fang Y, Chen S, Mo PKH, Wang Z. Knowledge and practice of personal protective measures against COVID-19 in Africa: systematic review. JMIR Public Health Surveill. 2023;9:e44051. doi:10.2196/44051</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/44051</ArticleId><ArticleId IdType="pmc">PMC10198719</ArticleId><ArticleId IdType="pubmed">37058578</ArticleId></ArticleIdList></Reference><Reference><Citation>The Royal Society. Policy project report. COVID-19: examining the effectiveness of non-pharmaceutical interventions; 2023. Available from: https://royalsociety.org/topics-policy/projects/impact-non-pharmaceutical-interventions-on-covid-19-transmission/. Accessed January
31, 2024.</Citation></Reference><Reference><Citation>World Health Organization. Achieving 70% COVID-19 Immunization Coverage by Mid-2022. Statement of the Independent Allocation of Vaccines Group (IAVG) of COVAX; 2021. Available from: https://www.who.int/news/item/23-12-2021-achieving-70-covid-19-immunization-coverage-by-mid-2022. Accessed January
31, 2024.</Citation></Reference><Reference><Citation>World Health Organization. Strategy to Achieve Global Covid-19 Vaccination by mid-2022; 2021. Available from: https://cdn.who.int/media/docs/default-source/immunization/covid-19/strategy-to-achieve-global-covid-19-vaccination-by-mid-2022.pdf. Accessed January
31, 2024.</Citation></Reference><Reference><Citation>Deml MJ, Githaiga JN. Determinants of COVID-19 vaccine hesitancy and uptake in sub-Saharan Africa: a scoping review. BMJ Open. 2022;12(11):e066615. doi:10.1136/bmjopen-2022-066615</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-066615</ArticleId><ArticleId IdType="pmc">PMC9676416</ArticleId><ArticleId IdType="pubmed">36400736</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel R, Forman R, Milstein R, et al. Divergent COVID-19 vaccine policies: policy mapping of ten European countries. Vaccine. 2023;41(17):2804&#x2013;2810. doi:10.1016/j.vaccine.2023.03.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.03.036</ArticleId><ArticleId IdType="pmc">PMC10030332</ArticleId><ArticleId IdType="pubmed">36967287</ArticleId></ArticleIdList></Reference><Reference><Citation>Wariri O, Afolabi MO, Mukandavire C, et al. COVID-19 vaccination implementation in 52 African countries: trajectory and implications for future pandemic preparedness. BMJ Glob Health. 2023;8(12):e013073. doi:10.1136/bmjgh-2023-013073</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2023-013073</ArticleId><ArticleId IdType="pmc">PMC10711863</ArticleId><ArticleId IdType="pubmed">38084478</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaseya J. A new model for public health in Africa can become a reality. Nature. 2023;621(7977):9. doi:10.1038/d41586-023-02749-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-023-02749-5</ArticleId><ArticleId IdType="pubmed">37670060</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor-Robinson SD, Taylor-Robinson AW. Are growing inequities leaving Africa behind in the post-pandemic public health landscape?. Pan Afr Med J. 2024;47(16). doi:10.11604/pamj.2024.47.16.41653</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2024.47.16.41653</ArticleId><ArticleId IdType="pmc">PMC10957726</ArticleId><ArticleId IdType="pubmed">38524111</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>